Experimental thrombosis and antiphospholipid antibodies: New insights

Journal of Autoimmunity

Volumn 15, Issue 2, 2000, Pages 241-247

  Pierangeli, Silvia S ^a   Gharavi, Azzudin E ^a   Harris, E Nigel ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Animal models; Antiphospholipid antibodies; Antiphospholipid syndrome; Lupus anticoagulant; Thrombosis

Indexed keywords

ANTIMALARIAL AGENT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; PHOSPHOLIPID ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPHOSPHOLIPID SYNDROME; CELL ACTIVATION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPERIMENTAL ANIMAL; FEMALE; IMMUNOTHERAPY; LEUKOCYTE ADHERENCE; LITTER SIZE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; THROMBOGENESIS; THROMBOSIS;

EID: 0033834768     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2000.0420     Document Type: Conference Paper

References (36)

1. Syndrome of the black swam
2. Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients
3. Immune mechanism for thrombosis: Antiphospholipid antibody binding to platelet membranes
4. Comparison of the effect of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation
5. Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expansion of procoagulant activity by cultured ECs
6. Inhibition of protein C activation by antiphospholipid antibodies in vitro is dependent on the composition of phospholipid (PL) liposomes used as template
7. Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
8. Impaired catalytic function of activated protein C; a new in vitro manifestation of lupus anticoagulant
9. 2Glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules
10. Anti-endothelial cell antibodies in patients with the antiphospholipid syndrome
11. Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S
12. Hypercoagulable states
13. 2glycoprotein I and induce endothelial activation
14. Activation of cultured vascular endothelial cells by antiphospholipid antibodies
15. Increased soluble vascular cell adhesion molecule 2 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: Correlations with the severity of thrombosis
16. 2glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome
17. Antiphospholipid antibodies from antiphospholipid syndrome patients activate ECs in vitro and in vivo
18. IgG fractions from patients with antiphospholipid antibodies cause fetal death in Balb/c mice: A model for autoimmune fetal loss
19. Induction of APS in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies
20. IgG anticardiolipin in murine lupus
21. Autoimmune MRL-lpr/lpr mice are an animal model for the secondary antiphospholipid syndrome
22. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice
23. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome
24. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome
25. Characterization of microvascular vasoconstriction following ischemia/reperfusion in skeletal muscle using video microscopy
26. Do leukocytes contribute to impaired microvascular tissue perfusion after arterial repair?
27. Hydroxychloroquine reverses thrombogenic properties of antiphospholipid antibodies in mice
28. A monoclonal IgG anticardiolipin antibody from a patients with the antiphospholipid syndrome in thrombogenic in mice
29. 2glycoprotein I and human IgG antiphospholipid antibodies
30. 2GPI) alone
31. GDKV-induced antiphospholipid antibodies enhance thrombosis and activate ECs in vivo and in vitro
32. Mononuclear phagocyte system in SLE, II. A kinetic model of immune complex handling in systemic lupus erythematosus
33. Induction of tissue factor-like activity in monocytes by anticardiolipin antibodies
34. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: Immunological changes associated with a successful outcome
35. Clinical uses of intravenous immunoglobulin in pregnancy
36. 2-microglobulin-containing neonatal intestinal transport receptor